Treatment of severe adverse cutaneous drug reactions with human intravenous immunoglobulin in two dogs

Tara K. Trotman, Heidi Phillips, Hilary Fordyce, Lesley G. King, Daniel O. Morris, Urs Giger

Research output: Contribution to journalArticlepeer-review

Abstract

Severe adverse cutaneous reactions were documented in two dogs with acute skin lesions and systemic signs after exposure to several oral and injectable drugs. Because of the high morbidity and mortality rates of many severe cutaneous drug reactions and a poor response to supportive care, wound management, and conventional immunosuppressive therapy, human intravenous immunoglobulin (IVIG) was infused on 2 consecutive days (1 g/kg per day) after informed consent was received. Human IVIG, with supportive care, resulted in rapid resolution of dermatological and systemic signs in both dogs; this treatment may be considered in other cases of severe cutaneous drug reactions.

Original languageEnglish (US)
Pages (from-to)312-320
Number of pages9
JournalJournal of the American Animal Hospital Association
Volume42
Issue number4
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

ASJC Scopus subject areas

  • Small Animals

Fingerprint

Dive into the research topics of 'Treatment of severe adverse cutaneous drug reactions with human intravenous immunoglobulin in two dogs'. Together they form a unique fingerprint.

Cite this